Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
ZTZoetis Inc. logo

Zoetis Inc. (ZTS)

New York Stock Exchange · Currency in USD
$81.03 ▼ -0.97 (-1.18%)
At close: Oct 23, 4:00 PM ET. Market closed.
$81.00 ▼ -0.03 (-0.04%)
After hours: Oct 23, 7:34 PM ET

Summary

Previous Close
$82.00
Open
$81.14
Day's Range
$80.65 – $81.86
52 Week Range
$68.77 – $147.93
Volume
2,501,052
Avg. Volume
5,565,870
Market Cap
$33.48B
Beta (5Y Monthly)
0.74
PE Ratio (TTM)
13.33
EPS (TTM)
$6.26
Earnings Date
Nov 5, 2026
Forward Dividend & Yield
$2.12 (2.62%)
Ex-Dividend Date
Oct 30, 2026
1y Target Est
$85.13

Profile: Zoetis Inc.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
14,500
CEO
Kristin C. Peck
Website
zoetis.com

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents.

Earnings

Next report: Thu, Nov 5, 2026
EPS estimate $1.51 · Revenue est. $2.30B
DateEst.Actual
Aug 6, 2026$1.85$1.87Beat
May 7, 2026$1.60$1.53Miss
Feb 12, 2026$1.40$1.48Beat
Nov 4, 2025$1.62$1.70Beat
Aug 5, 2025$1.62$1.76Beat
May 6, 2025$1.41$1.48Beat

Analyst view

Consensus price target
$85.13 ▲ +5.1%
Range $74.00 – $95.00
Rating: Hold
Buy 44% · Hold 56% · Sell 0%

Get free alerts on ZTS and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.